Urodynamic Testing: Can we Improve Patient Experience?

Urinary Incontinence Clinical Trial

Official title:

A Telephone Call to Decrease Patient Anxiety Before Urodynamic Testing: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02742389
• Other study ID #: 004-2016
• Status: Completed
• Phase: N/A
• First received: April 14, 2016
• Last updated: January 17, 2018
• Start date: April 2016
• Est. completion date: June 2017

Study information

• Verified date: January 2018
• Source: Boston Urogynecology Associates
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether an intervention (pre-procedure telephone call by the investigators) will reduce anxiety in women undergoing urodynamic testing (UDT) compared to usual care. Our hypothesis is that women who receive the intervention will report less anxiety immediately before UDT than women who receive usual care.

Description:

This is a non-blinded, randomized controlled trial. The clinical trial will investigate whether a telephone call by the investigator one week prior to urodynamic testing (UDT) will decrease patient pre-procedure anxiety, improve patient-reported preparedness and increase satisfaction compared to usual care. Patients who are scheduled for UDT will be informed about the study. If the patient agrees to participate in the study, she will be randomized to one of 2 groups based on the week of her scheduled UDT.

Group 1: Standard counseling. This group will receive the standard counseling that all Boston Urogynecology Associates (BUA) patients would receive if they are scheduled to have urodynamic testing. This counseling will include a description of the procedure and a handout about urodynamic testing. On the day of their test the participants will be asked to complete a brief survey about their experience before and after their testing. The investigators will also collect some information from their medical record, such as age and prior urogynecologic procedures.

Group 2: Standard counseling plus the intervention. The participants assigned to be in the intervention group will receive the standard counseling that all BUA patients who are scheduled for urodynamic testing receive (just like those who are assigned to group 1). This counseling includes a description of the procedure and a handout about urodynamic testing. In addition, the participants will receive a phone call from the investigators 1 week before their testing to talk about the procedure. The investigator calling the participant will document the duration of the phone call and any questions asked by the participant. On the day of their test the participants will be asked to complete the same surveys as group 1.

Surveys given to the participants on the day of their UDT appointment will include:

1. A pre-UDT questionnaire that includes questions on demographics, overall anxiety, anxiety about specific elements of procedure, self-reported preparedness and satisfaction.

2. A brief post-UDT questionnaire addressing test experience and pain.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 130
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. 18 years or greater

2. Female

3. Patients who have decided to schedule Urodynamic Testing to follow-up lower urinary tract dysfunction, pelvic organ prolapse, and/or urinary incontinence

Exclusion Criteria:

1. Pregnant

2. Presence of indwelling catheters

3. History of prior Urodynamic Testing

Related Conditions & MeSH terms

• Enuresis
• Lower Urinary Tract Symptoms
• Urinary Bladder, Overactive
• Urinary Incontinence

Intervention

Other:
• Preprocedure Telephone Call
The participants will receive a phone call from the investigators 1 week before their testing to talk about the procedure and answer any questions that patients may have . The investigator calling the participant will document the duration of the phone call and any questions asked by the participant

Locations

Country	Name	City	State
United States	Mount Auburn Hospital	Cambridge	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Boston Urogynecology Associates	Harvard University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Overall pre-procedure anxiety as measured on a visual analog scale.	Overall pre-procedure anxiety as measured on a visual analog scale.	Day 1